To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Wheelchairs: Health Services
Tuesday 17th February 2026

Asked by: Clive Jones (Liberal Democrat - Wokingham)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to make the recently developed service specification guidelines for wheelchair services mandatory across England.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchair services, based on the needs of their local population. NHS England supports ICBs to commission effective, efficient, and personalised wheelchair services and to reduce delays in people receiving timely intervention and wheelchair equipment.

This includes publishing a Wheelchair Quality Framework on 9 April 2025, which sets out quality standards and statutory requirements for ICBs. The framework is available at the following link:

https://www.england.nhs.uk/long-read/wheelchair-quality-framework/

NHS England also introduced personal wheelchair budgets, including legal rights in 2019, providing a clear framework for ICBs to commission personalised wheelchair services which are outcomes focused and integrated. Personal wheelchair budgets give people greater choice over the wheelchair provided.

Since July 2015, NHS England has collected quarterly data from ICBs on wheelchair provision, including waiting times, to enable targeted action if improvement is required. The latest figures from the Quarter 2 2025/26 National Wheelchair Data Collection showed that 84% of adults and 78% of children received their equipment within 18 weeks. Further information on the National Wheelchair Data Collection is available at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/nhse-national-wheelchair-data-collection/q2-2025-26

The Medium-Term Planning Framework sets a requirement for all providers and ICBs to actively manage long waits for community health services reducing the proportion of all waits over 18 weeks. This will be monitored via the NHS’s usual regional and national assurance processes.

The Community Health Services Situation Report, which will be used to monitor ICB performance against waiting time targets in 2026/27, currently monitors waiting times for both children and young people, and adult waiting times under the ‘Wheelchair, Orthotics, Prosthetics and Equipment’ line. These targets will guide systems to reduce the longest waits, and improvement initiatives to meet these targets may affect waits that are over 18-weeks and 52-weeks.


Written Question
Lipoedema
Tuesday 17th February 2026

Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how lipoedema is classified within NICE guidance and NHS commissioning frameworks; and whether he plans to review the categorisation of lipoedema-related interventions to ensure they reflect clinical need.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

Lipoedema services in England are commissioned locally by integrated care boards (ICBs), which are responsible for assessing the needs of their local populations and determining the most appropriate services to support people with long‑term conditions such as lipoedema.

There is no single national specification for lipoedema services. Instead, ICBs draw on a range of national guidance and best‑practice resources when designing care pathways. These include guidance from the National Institute for Health and Care Excellence (NICE) and best‑practice frameworks produced by bodies such as Wounds UK and the Royal College of General Practitioners. This helps ensure that services are safe, effective, and based on the best available evidence.

Most people with lipoedema are supported through primary and community care services, including assessment by local lymphoedema teams, compression therapy, advice on skin care and movement, and support with self‑management. These services aim to help people manage symptoms and maintain mobility and quality of life.

NICE classifies lipoedema within its interventional procedures guidance on the use of liposuction for chronic lipoedema, reference code HTG618, as a chronic, often painful, and progressive condition characterised by the abnormal, symmetrical accumulation of fat in the legs, hips, buttocks, and sometimes arms. In this guidance, NICE concluded that current evidence on both safety and effectiveness is limited and, therefore, recommends that liposuction should only be undertaken within the context of research or under rigorous governance arrangements. This guidance informs, but does not mandate, local commissioning decisions. NICE will review this guidance once the full results of the ongoing LIPLEG clinical trial are available, and will update its recommendations if new evidence supports doing so.


Written Question
Community Health Services: Homelessness
Tuesday 17th February 2026

Asked by: Tom Hayes (Labour - Bournemouth East)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps is the Department taking to remove barriers preventing community homelessness health services, such as mobile clinics, from accessing NHS SystemOne records.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

It is important that community health teams can access the information they need to provide quality care, including for people who are experiencing homelessness. NHS England and the Phoenix Partnership (TPP), the company that provides SystemOne, already offer several routes for some clinicians to view records outside of GP settings.

These include national services such as GP Connect and the National Care Records Service (NCRS), which allow clinicians to see key information from GP records. NCRS can also be used on mobile devices such as iPads. Integrated care systems are rolling out Shared Care Records, which give clinicians wider access to both GP and secondary care records, where appropriate.

More broadly, the Government’s commitments to improve health outcomes for people experiencing homelessness are set out in the cross-government strategy, A National Plan to End Homelessness. Through this strategy, we are working with NHS England, local authorities, and third sector partners to strengthen integrated care pathways. This includes improving collaboration between primary care, outreach teams, and community services. More information about the strategy is available at the following link:

https://www.gov.uk/government/publications/a-national-plan-to-end-homelessness/a-national-plan-to-end-homelessness

The Single Patient Record will enable improvements as it will provide a comprehensive view of health and care information across care settings. It will give both patients and professionals secure access to a single, accurate and up-to-date record – wherever and whenever it's needed.


Written Question
Chronic Fatigue Syndrome: Health Services
Tuesday 17th February 2026

Asked by: Jo Platt (Labour (Co-op) - Leigh and Atherton)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, in response to Question tabled on 15 December 2025, UIN 99871, if the Government can outline what steps are being taken to ensure the needs of people with severe Myalgic Encephalomyelitis are adequacy met.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The final delivery plan on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), published in July 2025, includes an action for the Department and NHS England to explore whether a specialised service should be prescribed by my Rt. Hon. Friend, the Secretary of State for Health and Social Care, for severe ME/CFS. Officials from the Department have commenced discussions with NHS England on how best to take forward this action.

The third and final session in NHS England’s newly-developed ME/CFS e-learning series, Managing Severe ME/CFS, is now live on the NHS Learning Hub. This session provides practical, evidence-based guidance for healthcare professionals to support people living with severe and very severe ME/CFS.

Additionally, as set out in the Plan for Change, we are committed to returning to the NHS constitutional standard that 92% of patients wait no longer than 18 weeks from referral to consultant-led treatment by March 2029. We exceeded our pledge to deliver an extra two million appointments, tests, and operations in our first year of government, having delivered 5.2 million additional appointments between July 2024 and June 2025. This will help people with severe ME/CFS to get support sooner.

The 10-Year Health Plan sets out a transformed vision for elective care by 2035, where most interactions no longer take place in a hospital building, instead happening virtually or via neighbourhood services. We will empower patients by giving them greater choice and control and establishing expected standards for making their experience of planned NHS care as smooth, supportive and convenient as possible, including for people with severe ME/CFS.


Written Question
Commodities: Health
Tuesday 17th February 2026

Asked by: Cat Smith (Labour - Lancaster and Wyre)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans his Department has to publish updated guidance on managing conflicts of interest between civil servants and Ministers in relation to unhealthy commodity industries.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department already has established arrangements in place to manage conflicts of interest for both ministers and civil servants, including where these relate to engagement with representatives of unhealthy commodity industries.

Ministerial conduct is governed by the Ministerial Code, which sets out requirements on the declaration and handling of ministers’ interests. Civil servants are bound by the Civil Service Code, and by departmental policies that set out how actual, potential, or perceived conflicts of interest must be identified, declared, and managed.

The Department keeps its internal guidance under regular review to ensure it remains aligned with cross-Government standards and supports transparent and accountable decision-making.


Written Question
Alcoholic Drinks: Public Health
Tuesday 17th February 2026

Asked by: Danny Beales (Labour - Uxbridge and South Ruislip)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to manage conflicts of interest associated with alcohol industry involvement in public health policy.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department already has established arrangements in place to manage conflicts of interest for both ministers and civil servants, including where these relate to the alcohol industry.

Ministerial conduct is governed by the Ministerial Code, which sets out requirements on the declaration and handling of ministers’ interests. Civil servants are bound by the Civil Service Code, and by departmental policies that set out how actual, potential, or perceived conflicts of interest must be identified, declared, and managed.

The Department keeps its internal guidance under regular review to ensure it remains aligned with cross-Government standards and supports transparent and accountable decision-making.


Written Question
Air Pollution: Health Hazards
Tuesday 17th February 2026

Asked by: Tim Farron (Liberal Democrat - Westmorland and Lonsdale)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of poor air quality in (a) ambient air and (b) indoor air on different age groups of people in England.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Poor air quality is a major public health risk in the United Kingdom. An estimated 29,000 to 43,000 deaths were attributable to long-term exposure to ambient air pollution in the UK in 2019 among adults aged 30 years old and over.

Indoor residential exposure to damp and mould was associated with approximately 5,000 cases of asthma and 8,500 lower respiratory infections among children, those who are aged between zero to 14 years old, and adults, those who are aged between 15 to 49 years old, in England in 2019.

The UK Health Security Agency (UKHSA) contributed to a report by the Royal College of Physicians in 2025. This contained data on new cases of mortality, myocardial infarction, asthma, lung cancer, and other conditions, attributable to a range of air pollutants in 2019 and predicted for 2040, among children, those over 30 years old, over 60 years old, and at all ages. The report is available at the following link:

https://www.rcp.ac.uk/policy-and-campaigns/policy-documents/a-breath-of-fresh-air-responding-to-the-health-challenges-of-modern-air-pollution/

The Department’s 10-Year Health Plan sets out how the Government will act to reduce the health harms of air pollution. This includes action to reduce harm from ambient air pollution and tackling poor indoor air by improving the standard of rented homes with relation to damp and mould.


Written Question
Life Sciences
Tuesday 17th February 2026

Asked by: Gregory Stafford (Conservative - Farnham and Bordon)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when the Government plans to establish a task and finish group to oversee delivery of the Life Sciences Sector Plan as it relates to generic and biosimilar medicines.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The United Kingdom’s world leading life sciences sector is central to our Industrial Strategy, driving growth, investment, and high-quality jobs. As set out in the Life Sciences Sector Plan, which we developed while working closely with the sector, there is an opportunity for the National Health Service to save £1 billion over five years through biosimilars uptake, delivering value for patients and the NHS. The Life Sciences Council is an important forum that brings together senior industry and Government leaders to shape the sector’s future. The Government remains committed to this partnership and is looking to convene the council in due course.

Medicines UK and its members are represented on the Single National Formulary Industry Task and Finish Group. In addition, the Government is working to convene further task and finish groups to drive forward defined areas of the Life Sciences Sector Plan, including in the generic and biosimilars space. These groups will direct focused ministerial and official attention toward a clear set of priorities and will work closely with industry to deliver tangible progress within a set timeframe.


Written Question
Members: Correspondence
Tuesday 17th February 2026

Asked by: Stuart Anderson (Conservative - South Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when he plans to reply to the email from the hon. Member for South Shropshire dated 24 October 2025 with case reference number SA36602.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department has received the Hon. Member’s letter and I will respond shortly.


Written Question
Wheelchairs: Health Services
Tuesday 17th February 2026

Asked by: Clive Jones (Liberal Democrat - Wokingham)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to ensure that NHS organisations and contracted wheelchair service providers are subject to more rigorous, mandatory regulation.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchair services, based on the needs of their local population. NHS England supports ICBs to commission effective, efficient, and personalised wheelchair services and to reduce delays in people receiving timely intervention and wheelchair equipment.

This includes publishing a Wheelchair Quality Framework on 9 April 2025, which sets out quality standards and statutory requirements for ICBs. The framework is available at the following link:

https://www.england.nhs.uk/long-read/wheelchair-quality-framework/

NHS England also introduced personal wheelchair budgets, including legal rights in 2019, providing a clear framework for ICBs to commission personalised wheelchair services which are outcomes focused and integrated. Personal wheelchair budgets give people greater choice over the wheelchair provided.

Since July 2015, NHS England has collected quarterly data from ICBs on wheelchair provision, including waiting times, to enable targeted action if improvement is required. The latest figures from the Quarter 2 2025/26 National Wheelchair Data Collection showed that 84% of adults and 78% of children received their equipment within 18 weeks. Further information on the National Wheelchair Data Collection is available at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/nhse-national-wheelchair-data-collection/q2-2025-26

The Medium-Term Planning Framework sets a requirement for all providers and ICBs to actively manage long waits for community health services reducing the proportion of all waits over 18 weeks. This will be monitored via the NHS’s usual regional and national assurance processes.

The Community Health Services Situation Report, which will be used to monitor ICB performance against waiting time targets in 2026/27, currently monitors waiting times for both children and young people, and adult waiting times under the ‘Wheelchair, Orthotics, Prosthetics and Equipment’ line. These targets will guide systems to reduce the longest waits, and improvement initiatives to meet these targets may affect waits that are over 18-weeks and 52-weeks.